Approval · Notice of Compliance 86 · 2003
ASAPHEN E.C.: Notice of Compliance 86
Issued April 9, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 86
- Date
- April 9, 2003
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Analgesic, anti-inflammatory, antipyretic and platelet aggregation inhibitor
- Canadian reference product
- COATED ASPIRIN DAILY LOW DOSE (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASAPHEN E.C. | Not yet assigned | — |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB